Wadih Jordan - Jun 15, 2021 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
/s/ Adam Krauss, as Attorney-in-Fact for Wadih Jordan
Stock symbol
AGEN
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 05:50 PM
Next filing
Oct 5, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option Award $0 +100K $0.00 100K Jun 15, 2021 Common Stock 100K $3.18 Direct F1
transaction AGEN Deferred Stock Units Award +6.87K +3.65% 195K Jul 1, 2021 Common Stock 6.87K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests in full on December 17, 2022.
F2 Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
F3 Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
F4 $3.820 per Deferred Stock Unit acquired on July 1, 2021. The price of each Deferred Stock Unit acquired prior to July 1, 2021 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.